DNA methylation at cytosine (5mC) is a key epigenetic modification that regulates gene expression, chromatin structure, and genome stability. Dysregulated methylation drives tumorigenesis, neurodegenerative diseases, and complex disorders. Directed Methylation Sequencing (DM-Seq) is a bisulfite free, enzymatic methyl sequencing technology that detects 5mC at single base resolution. It preserves DNA integrity, avoids harsh chemical damage, and enables accurate profiling even with low input or degraded samples.
Novogene offers flexible DM-Seq solutions tailored to your research needs:
• Illumina 5 base chemistry: Targets 5mC only, delivering clean, precise methylation calls ideal for standard epigenetics and SNV co detection studies.
• Watchmaker TAPS+ chemistry: Captures both 5mC and 5hmC, providing a comprehensive view of active epigenetic landscapes for neuroscience, development, and cancer research.












